Concern for the safety to the fetus is a commonly cited reason for vaccine refusal during pregnancy. Results from this investigation support the safety of seasonal influenza vaccination during pregnancy and suggest seasonal influenza vaccination may be protective against stillbirth.
Although antenatal influenza vaccination is an important public health intervention for 3 preventing serious infection in pregnant women and newborns, reported vaccine coverage is 4 often below 50%. Concern for the safety to the fetus is a commonly cited reason for vaccine 5 hesitancy and refusal. The incidence of stillbirth following pandemic vaccination has been 6 previously studied; however no population-based study has evaluated the incidence of 7 stillbirth following seasonal trivalent influenza vaccine (TIV). 8
Methods 9
We used probabilistic linking of perinatal and maternal vaccination records to establish a 10 cohort of 58,008 births occurring between April 2012 and December 2013. Stillbirth was 11 defined as birth ≥20 weeks gestation with an Apgar score of zero at one and five minutes 12
following delivery. Cox regression models adjusted for maternal smoking, Indigenous status 13 and propensity of vaccination were used to calculate adjusted hazard ratios (aHR) in 14 vaccinated and unvaccinated mothers. 15
Results

16
A total of 5,076 (8.8%) pregnant women received TIV and 377 stillbirths occurred. There were 17 5.0 and 3.0 stillbirths per 100,000 pregnancy days among unvaccinated and vaccinated 18 women, respectively. After adjustment, stillbirth was 51% less likely among vaccinated vs 19 unvaccinated mothers (aHR, 0.49; 95% confidence interval [CI], 0.29 to 0.84). The largest 20 relative reduction in stillbirths was observed for births occurring just after influenza season 21
(aHR, 0.33; 95% CI, 0.12 to 0.88). 22
Conclusions 23
Mothers who received seasonal TIV during pregnancy were significantly less likely to 24 experience stillbirth compared with unvaccinated mothers. These results support the safety of 25 seasonal influenza immunisation during pregnancy and suggest a protective effect. 26
Background 27
Pregnant women are at increased risk of serious complications following influenza infection, 28
including pneumonia and acute respiratory distress syndrome. [1] [2] [3] This increased risk is 29 thought to be the result of depressed cell-mediated immunity and physiological changes to the 30 cardiopulmonary system associated with pregnancy. 1, 3 Influenza infection during pregnancy 31 has also been linked to adverse fetal and neonatal outcomes, including increased risk of 32 preterm birth 1, 4 and fetal mortality; this effect has been most pronounced during influenza 33 pandemics. 2, 5, 6 During the recent 2009 influenza A/H1N1 pandemic, a significant increase in 34 perinatal mortality was observed following maternal infection, most of this attributable to a 35 four-fold increase in stillbirths. 5,7 36 37 Seasonal influenza vaccination has been shown to prevent infection in mothers and their 38 newborn infants, 8, 9 and the World Health Organization has indicated that pregnant women 39 should receive the highest priority for seasonal influenza vaccination. 10 Reported vaccine 40 uptake remains below 50% in pregnant women, and concern regarding the safety of the 41 vaccine for the fetus is a commonly cited reason why women refuse vaccination. 11-12 42 Enhanced data collection and surveillance during the 2009 H1N1 pandemic offered the unique 43 opportunity to monitor the safety of pandemic influenza vaccination in large, observational 44 studies. 13 These studies suggested stillbirth was less common in women who received 45 pandemic vaccine compared to unvaccinated women, supporting the safety of pandemic 46 influenza vaccination during pregnancy; 5, [13] [14] [15] [16] however, to date, no population-based study 47 has been conducted to evaluate the impact of antenatal administration of seasonal influenza 48 vaccination on stillbirth during non-pandemic influenza seasons. 13, 16 The aim of this study was 49 to assess the relative risk of stillbirth among vaccinated and unvaccinated pregnant women 50 during the 2012 and 2013 seasonal influenza epidemics in the winter months of the southern 51 hemisphere. 52 
Methods
Data sources
61
Vaccination status 62
Seasonal trivalent influenza vaccine has been provided at no cost under the National 63
Immunisation Program to pregnant women since 2009 and has been part of routine antenatal 64 care in Western Australia since 2012. Post-partum surveys estimate that 25-36% of women 65 who were pregnant during the study period received seasonal trivalent influenza vaccine. 17 
66
The majority of pregnant women in Australia receive their influenza vaccine from general 67 practitioners; an additional 19% are immunised at public hospital antenatal clinics. 17 As part 68 of ongoing vaccine safety surveillance, providers administering influenza vaccine during 69 pregnancy under the National Immunisation Program are asked to inform the Western 70
Australia Department of Health of the name, date of birth, and vaccination date of the 71 expectant mother. This information is stored in the Western Australia Antenatal Influenza 72
Vaccination Database. In our cohort, women with a vaccination record in the database with a 73 date of influenza vaccination occurring between the estimated date of conception (based on 74 gestation) and 14 days prior to date of delivery were defined as vaccinated during pregnancy. The Midwives Notification System is a legally mandated data collection system which requires 79 the healthcare professional attending the birth to provide information at the time of delivery 80 related to the pregnancy for all births in Western Australia ≥20 weeks gestation. 18 The midwife 81
in attendance usually submits birth information to the system; however, in the absence of a 82 midwife the medical officer is asked to submit the information. If there is no midwife or medical 83 officer in attendance, the first qualified midwife or medical offer to attend would submit the 84 information. In Western Australia, 98% of births occur in hospital (59% of which are public), 85
and 1% occur at a birth centre, all of which are staffed by midwives. 18 The remaining 1% of 86 births occur at home, which may or may not be attended by a midwife. The Midwives 87
Notification System is thought to include 99% of births in the state. 19 
Midwives Notification 88
System data include the date of birth, birth weight, postcode of residence, status of the baby 89 at birth (alive or dead), Apgar scores at one and five minutes after delivery, medical conditions 90 of the mother, and complications related to the pregnancy and delivery. Gestation provided in 91
Midwives Notification System data is estimated based on a previously validated algorithm 92 drawing from both antenatal indicators (e.g. expected due date) and neonatal indicators of 93 gestation (e.g. sole creases, scalp hair). 20 Stillbirth was defined as a birth where the infant was 94 recorded as stillborn by the clinician and had an Apgar score of zero at one minute and five 95 minutes following birth. This definition is consistent with previously published definitions. 21 96
Maternal characteristics 97
Maternal age, pre-existing medical conditions, the occurrence of medical complications during 98 pregnancy (including pre-eclampsia, gestational diabetes, threatened abortion, threatened 99 preterm labour and urinary tract infections), and smoking during pregnancy (yes/no) were 100 obtained from the midwives' records. Indigenous status was defined using a previously 101 validated algorithm drawing from multiple government administrative data sets. 22 The 102 statistical local area of the mother at the time of birth was used to calculate a Socio-Economic 103
Indexes for Areas (SEIFA) score. Statistical local areas are Australian Standard Government 104
Classification defined local areas which cover the whole of Australia. SEIFA is comprised of several indices, the main index being that of relative disadvantage which is derived from low 106 income, low educational attainment, high unemployment and jobs in unskilled 107 occupations. 23 SEIFA scores were grouped into quintiles. Statistical local areas were also used 108 to assign individuals into levels of remoteness of their residence based on the Accessibility 109 and Remoteness Index (ARIA) scale, a national index developed by the National Centre for 110 Social Applications of Geographic Information Systems. ARIA scores are based on road 111 distance measurements from the statistical local area of residence to the nearest populated 112 locality greater than 1,000 persons; scores range from one (highly accessible) to five (highly 113 remote). 24 114
Statistical analysis 115
The odds of vaccination and stillbirth were compared by maternal characteristics using 116 binomial logistic regression models. The odds of stillbirth were also compared by influenza common in our cohort in women with higher risk pregnancies, 17,21 models were adjusted by 131
propensity of vaccination to avoid potential confounding by indication. Propensity scores for vaccination were derived from a logistic regression model with maternal age, SEIFA and ARIA 133 scores, primiparity, multiple births, pre-existing medical conditions, and complications of 134 pregnancy as independent variables and vaccination status as the dependent variable. 135
Propensity scores ranged from -0.68 to 1.07 (median: 0.23, IQR: 0.05, 0.44). Models were 136 also adjusted for Indigenous status of the mother and self-reported smoking during pregnancy. 137
138
To estimate the effect in births following influenza season compared to the effect in births prior 139 to influenza season, we calculated a ratio of hazard ratios using the approach outlined by 140
Altman and Bland. 27 Hazards regression models were also created to compare the risk of 141 stillbirth in preterm pregnancies (<37 weeks) and full-term pregnancies (≥37 weeks), and for 142 five levels of propensity for vaccination (strata 1, -0.69-0.01; strata 2, 0.02-0.15; strata 3, 0.16-143 0.30; strata 4, 0.31-0.50; strata 5, 0.51-1.07). All covariates were tested to determine whether 144 models met the assumption of proportional hazards (α=.05). 145
Results
146
A total of 59,333 midwives records were provided for linkage with a date of birth from 1 April 147 2012 to 31 December 2013. Of these, 1,325 were excluded because the mother resided 148 outside of Western Australia (n=71) or had missing covariate information (n=1,254), leaving 149 58,008 births for analysis. A total of 5,541 births were linked to an influenza vaccination record 150 of which 5,076 (92%) had a date of administration 14 days or more prior to the date of delivery. 151 Therefore, the final dataset included 58,008 births, 5,076 to vaccinated mothers and 52,932 152 to unvaccinated mothers (Figure 2 ), contributing 7,716,084 days of follow-up during pregnancy 153 (462,808 days vaccinated and 7,253,276 days unvaccinated). The majority of births included 154 in the analysis were to mothers who were <35 years of age (80%), non-Indigenous (94%), and 155 in the top 20% socioeconomic (SEIFA) level (65%); 44% resided in a metropolitan area.
Overall, 8.7% of the cohort received seasonal influenza vaccine during their pregnancy (6.9% 158 in 2012% and 10.2% in 2013). The proportion of births to vaccinated mothers ranged from 159 0.5% in April 2012 to 15.8% in August 2013, with the number of doses administered to 160 pregnant women peaking in April each year (Figure 1) Women with pre-existing medical conditions were more likely to receive an influenza vaccine 167 (OR, 1.46; 95% CI, 1.38 to 1.54), as were women with pre-eclampsia (OR, 1.32; 95% CI, 1.11 168 to 1.57) or gestational diabetes (OR, 1.34; 95% CI, 1.21 to 1.48). Primiparous women and 169 women with multiple births were also more likely to be vaccinated compared to multiparous 170 and women with a singleton pregnancy (OR, 1.14; 95% CI, 1.07 to 1.21 and OR, 1.35; 95% 171 CI, 1.15 to 1.58, respectively) ( Table 1) . 172
Stillbirth 173
During the observation period, 377 stillbirths occurred, equating to 6.5 per 1,000 births overall. 174
Stillbirth was more common among women with diabetes (OR, 2.93; 95% CI, 1.44 to 5.93) or 175 hypertension (OR, 1.92; 95% CI, 1.92 to 5.88), women who smoked during pregnancy (OR, 176 1.42; 95% CI, 1.07 to 1.89), and Indigenous women (OR, 2.04; 95% CI, 1.47 to 2.83) ( Table  177 2). Stillbirth was less common among women in the highest socioeconomic level (OR, 0.66; 178 95% CI, 0.44 to 0.99) and women residing in highly accessible areas (OR, 0.66; 95% CI, 0.46 179 to 0.97). Women with a multiple pregnancy had four times the odds of stillbirth compared to 180 women with a singleton pregnancy (OR, 4.08; 95% CI, 2.89 to 5.75). The majority (66.4%) of 181 stillbirths in the cohort occurred between 20 and 27 weeks gestation. Although not statistically 182 significant, stillbirth was more common during post-influenza season compared with pre-183 influenza season (p=0.07) ( Table 2 ).
The unadjusted incidence of stillbirth in unvaccinated mothers was 5.0 per 100,000 pregnancy 186 days compared with 3.0 per 100,000 pregnancy days in vaccinated women ( Table 3 ). The 187 adjusted risk of stillbirth was 51% lower among vaccinated women compared to unvaccinated 188 women (adjusted hazard ratio (aHR), 0.49; 95% CI, 0.29 to 0.84). Of the 465 women who 189 were vaccinated <14 days before the date of delivery, i.e. classified as unvaccinated for this 190 analysis, none had a stillbirth. When comparing the rate of stillbirth by gestational age, a 191 significant reduction in stillbirths among vaccinated mothers was only observed for stillbirths 192 occurring prior to 37 weeks of gestation (aHR, 0.45; 95% CI, 0.26 to 0.81). There was a non-193 significant reduction in stillbirth associated with maternal influenza vaccination prior to the start 194 of the influenza season (aHR, 0.60; 95% CI, 0.22 to 1.61) and during the influenza season 195 (aHR, 0.57; 95% CI, 0.25 to 1.31); however, a greater and significant reduction was observed 196 for births occurring during the post-influenza season period (aHR, 0.33; 95% CI, 0.12 to 0.88) 197
( Figure 3 ). The ratio of hazards ratios during the post-influenza season period compared to 198 the pre-influenza season period was 0.55 (95% CI, 0.13 to 2.49), suggesting the effect of 199 vaccination may be greater following influenza season. 200
Discussion
201
To our knowledge, this is the first population-based study of seasonal trivalent influenza 202 vaccine and stillbirth, and the largest cohort study to date evaluating maternal vaccination and 203 stillbirth. We observed a reduced hazard of stillbirth associated with seasonal trivalent 204 influenza vaccine administered during pregnancy after controlling for risk factors for stillbirth 205 and accounting for factors associated with disproportionate uptake of maternal vaccination. 206
These results are consistent with those of previous large cohort studies investigating the 207 perinatal impact of pandemic and monovalent influenza vaccination in pregnancy [13] [14] [15] [16] 26 and 208 support the safety of antenatal administration of seasonal trivalent influenza vaccine. 209
Several findings in our study support an association between influenza infection and stillbirth. 211
The observed rate of stillbirth was higher following periods of influenza virus circulation (e.g. 212
November through December) compared to periods prior to influenza season (e.g. January 213
through May). Although seasonal differences were not statistically significant (p=0.07), these 214 results suggest a possible temporal association between stillbirth and influenza season. 215
Researchers in Finland observed seasonal patterns in the population incidence of stillbirth, 216 with the highest rates of stillbirth occurring just after influenza season in the northern 217 hemisphere (March) and the lowest rates in summer and autumn. 28 Furthermore, the effect 218 estimate between vaccination and stillbirth was greater during the post-influenza season 219 period compared to the pre-influenza season period. Additional studies should further evaluate 220 the possible temporal association between stillbirth and influenza season. 221
222
Our results are consistent with those of previous large cohort studies of maternal influenza 223 vaccination during an influenza pandemic. [13] [14] [15] 26 Although observational cohort studies, such 224 as ours, are subject to potential bias, including uncontrolled confounding due to the nature of 225 the study design, 13 there are several strengths to this large observational cohort study. First, 226 observational cohort studies are the most efficient method of measuring the impact of maternal 227 influenza vaccination on stillbirth, given the relatively low incidence of stillbirth in developed 228 countries and potentially low uptake of vaccine. 13 With an incidence of 6.4 stillbirths per 1,000 229 births in Australia, 29 other study designs such as randomised controlled trials would be 230 implausible, as well as unethical, given that maternal influenza vaccination is now 231 recommended as standard of care. Second, previous observational, cohort studies have taken 232 measures to prevent uncontrolled confounding, including propensity score adjustment 26 and 233 controlling for known maternal risk factors, 15 and have observed a significant protective effect 234 of maternal vaccination. Similar to these investigations, we stratified our analyses by the 235 mother's propensity for vaccination and adjusted for known maternal risk factors for stillbirth. 236
Despite the strengths of this cohort study, there are several limitations to our cohort which 240 should be considered. Measurement of vaccination status in this cohort is thought to have 241 been incomplete. In the absence of a registry of adult vaccinations in Australia, we relied on 242 provider-reported vaccination events and there was no legal requirement to report these 243
vaccinations. An evaluation of the completeness of reporting for maternal influenza 244 vaccinations in Western Australia found that approximately half (46%) get reported to the state 245 vaccination database. 30 In addition, a post-partum survey of mothers in Western Australia who 246 delivered in April through October in 2012 and 2013 indicated that 26% and 36% (respectively) 247 had received an influenza vaccination during the study period. 17 In our cohort, 9% and 14% of 248 mothers were reportedly immunised during these respective time periods. However, because 249 false positives (i.e. reporting a vaccination when one did not occur) are very unlikely in the 250 vaccination database, 30 exposure misclassification in our cohort would likely bias our results 251 toward the null, indicating the protective effect between vaccinations and stillbirths that we 252 observed may be an underestimate of the true effect measure. Second, our cohort was 253 restricted to the Australian setting over two influenza seasons; therefore our results may not 254 be generalizable to developing countries, where stillbirth is more common, or influenza 255 seasons for which the protection afforded by the vaccine might be different. Finally, due to low 256 number of outcomes in our dataset, we were unable to compare the safety of seasonal 257 influenza vaccine by trimester of administration. Future research should examine whether the 258 lower incidence of stillbirth associated with antenatal influenza vaccinations we observed is 259 applicable to other influenza seasons and settings and across trimesters of vaccine 260 administration. 261
Conclusions 262
Our results support the safety of maternal influenza vaccination, as we found no increase in 263 the risk of stillbirth in vaccinated women. Additional research is needed to confirm the potential 264 reduction in stillbirth observed in this cohort study. There are over three million stillborn infants each year worldwide, and in developed countries stillbirth accounts for 70% of perinatal 266 deaths; 31 confirmation of these findings would indicate seasonal influenza vaccination in 267 pregnancy has substantial perinatal health benefits. These results may be useful for 268 communicating the potential benefits of seasonal influenza vaccination to pregnant mothers 269 and their providers. Given the growing body of evidence supporting the health benefits to 270 mother and infant, concerted efforts are needed to improve seasonal influenza vaccine 271 coverage among pregnant women. 272 
